6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
13m ago	Timberland Bancorp Reports Second Fiscal Quarter Net Income of $7.1 Million
39m ago	CPKC increases dividend by 17.5 percent
39m ago	Waldencast announces conclusion of SEC investigation
40m ago	Nektar to Announce Financial Results for the First Quarter on Thursday, May 7, 2026, After Close of U.S.-Based Financial Markets
40m ago	F5 to Host Analyst and Investor Meeting on May 28, 2026

About

Cytokinetics Inc (NASDAQ:CYTK) — investor relations, events, news, and company updates on 6ix.

Latest News

Cytokinetics to Announce First Quarter Results on May 5, 2026

Cytokinetics to Participate in the 25th Annual Needham Virtual Healthcare Conference

Cytokinetics Announces Four Presentations at the American College of Cardiology Annual Scientific Session & Expo

Cytokinetics Reports Fourth Quarter 2025 Financial Results and Provides Business Update

Cytokinetics Announces European Commission Approval of MYQORZO® (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Financials

Revenue

$88.04 M

Market Cap

$8.22 B

EPS

-6.54

Community Chat

Ask AI